Dexcom Inc Stock Annual Yield
| DC4 Stock | EUR 73.54 0.92 1.24% |
DexCom Inc fundamentals help investors to digest information that contributes to DexCom's financial success or failures. It also enables traders to predict the movement of DexCom Stock. The fundamental analysis module provides a way to measure DexCom's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to DexCom stock.
DexCom |
DexCom Inc Company Annual Yield Analysis
DexCom's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
| Competition |
In accordance with the recently published financial statements, DexCom Inc has an Annual Yield of 0.0%. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Diagnostics & Research (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
DexCom Annual Yield Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses DexCom's direct or indirect competition against its Annual Yield to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of DexCom could also be used in its relative valuation, which is a method of valuing DexCom by comparing valuation metrics of similar companies.DexCom is currently under evaluation in annual yield category among its peers.
DexCom Fundamentals
| Return On Equity | 0.16 | |||
| Return On Asset | 0.0474 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.13 % | |||
| Current Valuation | 42.38 B | |||
| Shares Outstanding | 386.41 M | |||
| Shares Owned By Insiders | 0.42 % | |||
| Shares Owned By Institutions | 99.58 % | |||
| Price To Earning | 191.84 X | |||
| Price To Book | 24.95 X | |||
| Price To Sales | 15.73 X | |||
| Revenue | 2.91 B | |||
| Gross Profit | 1.88 B | |||
| EBITDA | 565.3 M | |||
| Net Income | 341.2 M | |||
| Cash And Equivalents | 1.38 B | |||
| Cash Per Share | 15.11 X | |||
| Total Debt | 1.2 B | |||
| Debt To Equity | 159.90 % | |||
| Current Ratio | 6.05 X | |||
| Book Value Per Share | 5.52 X | |||
| Cash Flow From Operations | 669.5 M | |||
| Earnings Per Share | 0.75 X | |||
| Price To Earnings To Growth | 11.47 X | |||
| Target Price | 530.6 | |||
| Number Of Employees | 7.5 K | |||
| Beta | 1.11 | |||
| Market Capitalization | 40.57 B | |||
| Total Asset | 5.39 B | |||
| Z Score | 19.8 | |||
| Net Asset | 5.39 B |
About DexCom Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze DexCom Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DexCom using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DexCom Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in DexCom Stock
When determining whether DexCom Inc is a strong investment it is important to analyze DexCom's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact DexCom's future performance. For an informed investment choice regarding DexCom Stock, refer to the following important reports:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DexCom Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..